LaNCE-Neuropharm - GIC 21/133
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Vall d'Hebron (6)
2022
-
Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes
Parkinsonism and Related Disorders, Vol. 94, pp. 67-78
2021
-
Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations
Journal of Neurotrauma, Vol. 38, Núm. 18, pp. 2514-2529
2017
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
Variation in structure and process of care in traumatic brain injury: Provider profiles of European Neurotrauma Centers participating in the CENTER-TBI study
PLoS ONE, Vol. 11, Núm. 8
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218